Genzyme Investors Urge 1st Circ. To Revive Fraud Action
A group of Genzyme Corp. investors on Monday urged the First Circuit to revive a putative consolidated class action accusing the company of lying about contamination at a key production plant,...To view the full article, register now.
Already a subscriber? Click here to view full article